Sitalakshmi Elango, MD | |
300 2nd Ave, Long Branch, NJ 07740-6303 | |
(201) 804-2800 | |
Not Available |
Full Name | Sitalakshmi Elango |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Location | 300 2nd Ave, Long Branch, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821095340 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 25MA06367400 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sitalakshmi Elango, MD Po Box 1637, Elizabeth, NJ 07207-1637 Ph: (201) 804-2800 | Sitalakshmi Elango, MD 300 2nd Ave, Long Branch, NJ 07740-6303 Ph: (201) 804-2800 |
News Archive
A team of researchers from Spain and Latin America have synthesized two iron compounds that inhibit the in vitro growth of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Due their low level of toxicity in mammel cells, the compounds could be used in the future as therapeutic agents and hospital disinfectants.
How do we make decisions about a situation we have not encountered before? New work from the Center for Mind and Brain at the University of California, Davis, shows that we can solve abstract problems in the same way that we can find a novel route between two known locations -; by using an internal cognitive map.
"Facing a squall of condemnation from aid groups and opposition politicians," following statements by Canadian Foreign Minister Lawrence Cannon that Canada's G8 maternal and child health initiative would not include family planning, Prime Minister Stephen Harper "disavowed his foreign minister Thursday, promising that the federal government would include contraception programs in its maternal-health foreign-aid initiative," the Globe and Mail reports.
Three studies presented by University of Colorado Cancer Center researchers at the San Antonio Breast Cancer Symposium 2014 demonstrate the effects of blocking androgen receptors in breast cancer.
Cellectar, Inc., a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
› Verified 3 days ago
Dr. Matthew Phillip Zlotnick, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 Second Ave, Long Branch, NJ 07740 Phone: 732-923-6980 | |
Dr. David C Kramer, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 | |
Michael H Flashburg, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 | |
Dr. Mark Jack Der Mesropian, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 | |
Matthew Klein, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 300 Second Avenue, Monmouth Medical Center, Long Branch, NJ 07740 Phone: 732-222-5200 | |
Debra J Molbegott, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 279 3rd Ave, Long Branch, NJ 07740 Phone: 732-222-7373 Fax: 732-229-1556 | |
Dr. Joshua Lyn Spruell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Ste 251, Long Branch, NJ 07740 Phone: 732-923-6769 |